FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like <b>Epicore BioNetworks Inc.</b> Reports Quarter Three Results For Fiscal Year 2017 For The Quarter Ended 31 March 2017, In U.S. Dollars May 17, 2017 FDA Release: Mutual Recognition Promises New Framework For Pharmaceutical Inspections For United States And European Union March 1, 2017 Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest November 29, 2017
<b>Epicore BioNetworks Inc.</b> Reports Quarter Three Results For Fiscal Year 2017 For The Quarter Ended 31 March 2017, In U.S. Dollars May 17, 2017
FDA Release: Mutual Recognition Promises New Framework For Pharmaceutical Inspections For United States And European Union March 1, 2017
